Skip to main content
. 2024 May 8;24(1):96. doi: 10.1007/s10238-024-01357-5

Table 4.

Comparisons of organ involvement rate among patients with positive anti-SSA, positive anti-SSB, both positive, and both negative groups

Anti-SSA positive group Anti-SSB positive group Double-positive group Double-negative group χ2 P
n = 301 n  = 2  n= 168 n = 80
Skin mucosal involvement rate 54 (17.90%) 0 (0.00%) 28 (16.70%) 12 (15.00%) 0.541 0.886
Musculoskeletal involvement rate 92 (30.60%) 1 (50.00%) 51 (30.40%) 30 (37.50%) 2.253 0.496
Renal system involvement rate 7 (2.30%) 0 (0.00%) 5 (3.00%) 0 (0.00%) 3.451 0.358
Renal tubular acidosis 7 (2.30%) 0 (0.00%) 5 (3.00%) 0 (0.00%) 3.451 0.358
Respiratory system involvement rate 53 (17.60%) 0 (0.00%) 28 (16.70%) 8 (10.00%) 2.904 0.389
Interstitial pneumonia 40 (13.30%) 0 (0.00%) 16 (9.50%) 5 (6.30%) 4.050 0.256
Digestive system involvement rate 73 (24.30%) 1 (50.00%) 28 (16.70%) 8 (10.00%) 5.126 0.154
Autoimmune hepatitis 23 (7.60%) 1 (50.00%) 5 (3.00%) 11 (13.80%) 15.076 0.007
Blood system involvement rate 95 (31.60%) 0 (0.00%) 25 (14.90%) 12 (15.00%) 19.353  <0.001
Immune thrombocytopenia 36 (12.00%) 0 (0.00%) 16 (9.50%) 5 (6.30%) 2.646 0.449
Thyroid involvement rate 58 (19.30%) 0 (0.00%) 25 (14.90%) 12 (15.00%) 1.866 0.612